Mobile 3D Global Market Report 2023 – By Type (Tablets, Smartphones, Notebooks, Other Types), By Device Component (Image Sensors, 3D Displays), By Application (Animations, Maps And Navigation, Mobile Gaming, Mobile Advertisements, Other Applications) – Market Size, Trends, And Global Forecast 2023-2032

3D printed implants are artificial devices used to replace a missing or damaged biological structure in the body and are manufactured by laying successive layers of material using inputs from a digital 3D model. The main implantation technologies in 3D printed medical implants are laser beam melting, electronic beam melting, droplet deposition, laminated deposition, and two-photon polymerization. The laser beam melting is a manufacturing process in which 3D components are digitally cut into 2D layers by using a high-performance laser to melt and bond at these points. The various applications include are dental, orthopedic, and craniomaxillofacial that are used by end-users such as medical and surgical centres, pharmaceutical companies, the biotechnology industry, and medical institutions. The global 3D printed implants market is segmented - 1) By Application: Dental, Orthopedic, Cranio-maxillofacial 2) By End Users: Medical And Surgical Centers, Pharmaceutical Companies, Biotechnology Industry, Medical Institution 3) By Implantation Technology: Laser Beam Melting, Electronic Beam Melting, Droplet Deposition, Laminated Deposition, Two-photon Polymerization The global 3D printed implants market size will grow from $2.25 billion in 2022 to $2.67 billion in 2023 at a compound annual growth rate (CAGR) of 18.9%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The market size of global 3D printed implants is expected to grow to $5.36 billion in 2027 at a CAGR of 19.0%. The increasing prevalence of various medical conditions is driving the growth of the 3D printed implants market. As the number of people suffering from orthopedic, cardiac, and dental diseases is increasing, the demand for 3D dental crowns, 3D dental bridges, 3D acetabular hip implants, shoulder implants, and various other implants is rising. According to the World Health Organization (WHO), the US had around 65 million people suffering from periodontitis i.e. Inflammation and infection of the ligaments and bones that support the teeth. This mainly occurred due to the rising prevalence of periodontitis, diabetes-related gangrene, osteoarthritis, and peripheral vascular disease. Similarly, the rise in prevalence of other medical conditions is driving the demand for use of 3D printed implants industry. Major players in the 3D printed implants market are 3D Systems Corporations, Stratasys Ltd., Arcam AB, EnvisionTEC, SLM Solutions Group AG, Organovo HoldingsInc., Oxford Performance Materials, Materialise, Cyfuse Biomedical K.K., and Bio3D Technologies. The stringent approval process for the selection of a new material to be used in 3D implants is a time-consuming process that acts as a restraint for the 3D printed implants market. 3D Printing requires high-quality materials that should adhere to specific criteria set by regulatory bodies such as US FDA. These regulatory bodies provide procedure guidelines, requirements, and monitor material quality control. For example, the US FDA approved spinal implants made from titanium alloy, but it didn't approve titanium alloy to be used in any other medical device. For each new use of the material, manufacturing companies need to get approval again from regulatory bodies. This causes a lag in the manufacturer's operational cycle and delays the product launch, thus affecting sales and restraining the growth of the 3D printed implants market. Many companies in this market are collaborating with various hospitals and rehabilitation centres to provide customizable devices for the specific needs of patients. These collaborations are aimed to be mutually beneficial for both, as the companies can use the network of the hospitals to promote their product and the hospitals would get customizable devices at their convenience. For example, In September 2022, the US Food and Drug Administration (FDA) announced a collaboration with Veterans Health Administration (VHA) to encourage innovation in the 3D medical devices and implants. Similarly, in July 2022, Envista Holdings Corporation announced commercial partnership with dentalcorp Holdings to develop dental implants. The US FDA's Center for Devices and Radiological Health (CDRH) is the regulatory authority for companies that manufacture, repackage, relabel, and/or import medical devices sold in the United States. The medical devices made using 3D printing technology are subject to regulatory requirements before they are marketed (premarket requirements), and also after they are marketed (post-market requirements). FDA classifies 3D printed medical devices into three classes, i.e., Class I, II, and III, with regulatory controls minimum for class I devices and maximum for class III devices. Most class III devices require premarket approval whereas class I devices are exempted from the approval. The manufacturers of 3D printed medical implants are required to establish and follow quality systems to ensure that their products consistently meet applicable requirements and specifications. The manufacturers also need to comply with FDA's standards regarding device design, manufacturing, and testing considerations during the development of 3D printed medical devices. In 2020, Stryker has announced the acquisition of Wright Medical Group N.V., for an undisclosed amount. This acquisition increases Stryker global market position in trauma and extremities, issuing crucial opportunities to advance creativity and reach more patients. Wright Medical Group N.V., is US- based Company is a medical device company focused on extremities and biologics. North America was the largest region in the 3D printed implants market in 2022. Asia-Pacific was the second-largest region in the 3D printed implants market report. The regions covered in the 3D printed implants industry are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa. The countries covered in the 3D printed implants market are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, and USA. The 3D printed implants market consists of sales of 3D implants created by technologies such as laser beam melting, electronic beam melting, droplet deposition, laminated deposition, and two-photon polymerization. The market value includes the value of related goods sold by the service provider or included within the service offering. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The 3D printed implants market research report is one of a series of new reports from The Business Research Company that provides 3D printed implants market statistics, including 3D printed implants industry global market size, regional shares, competitors with a 3D printed implants market share, detailed 3D printed implants market segments, market trends and opportunities, and any further data you may need to thrive in the 3D printed implants industry. This 3D printed implants market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Cell culture is a process for developing substrates for the safe production of viral vaccines. 3D cell culture is an in vitro technique wherein the cells can grow in an artificially created environment. The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the chain or as part of other products. The main types of 3D cell culture technologies are scaffold-based, scaffold-free, and 3D bioreactors. The 3D bioreactors are small plastic cylinder chambers designed specifically for growing cells in three dimensions. The various scaffold-based technologies include hydrogels, polymeric scaffolds, micropatterned surface microplates and the different scaffold-free technologies are hanging drop microplates, spheroid microplates, microfluidic 3d cell culture, magnetic levitation and 3D bioprinting. The technologies are applied for cancer research, stem cell research, drug discovery, and regenerative medicine that are used by research laboratories and institutes, biotechnology and pharmaceutical companies, hospitals and diagnostic centers, and other end users. The global 3D cell culture technologies market is segmented – 1) By Type: Scaffold-based, Scaffold-free, 3D Bioreactors 2) By End Users: Research Laboratories and Institutes, Biotechnology and Pharmaceutical Companies, Hospitals and Diagnostic Centers, Other End Users 3) By Scaffold-based: Hydrogels, Polymeric scaffolds, Micropatterned Surface Microplates 4) By Scaffold-free: Hanging Drop Microplates, Spheroid Microplates, Microfluidic 3D Cell Culture, Magnetic Levitations & 3D Bioprinting 5) By Application: Cancer Research, Stem Cell Research, Drug Discovery, Regenerative Medicine The global 3d cell culture technologies market size grew from $2.39 billion in 2022 to $2.83 billion in 2023 at a compound annual growth rate (CAGR) of 18.2%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The market size of the 3d cell culture technologies market is expected to grow from $5.65 billion in 2027 at a CAGR of 18.9%. The increasing requirement for organ transplantation is driving the 3D Cell Culture Technologies Market. 3D cell culture helps in forming a three-dimensional structure which further helps in mimicking the tissue or organ and therefore helps in organ transplantation. 3D cell structures are capable of tissue and organ regeneration as well as providing the provision for drug toxicology screening. For instance, according to the Organ Procurement and Transplantation network, an American non-profit organization administering the organ transplantation in the US, 41,354 organ transplantations were performed in the United States in 2021 which was an increase of 5.9% as compared to 2020 and the number exceeded 40,000 mark for the first time ever. Major players in the 3D cell culture technologies market are Becton Dickinson, Corning Incorporation, Eppendorf, GE Healthcare, Merck KGaA, Thermo Fisher Scientific, Lonza, HiMedia Laboratories, Agilent Technologies, PromoCell GmbH, CellGenix GmbH, InvivoGen, Greiner Bio-One, Irvine Scientific, Cell Culture Company (CCC) LLC., Sera Care Life Sciences Incorporation, American Type Culture Collection, Miltenyi Biotec, AITbiotech, ESSEN, Sigma-Aldrich, Bel-Art, MilliporeSigma, Cellgenix, Sumitomo Bakelite, EMD Millipore, AffymetrixInc., VWR International, LLC., WHEATON IndustriesInc., and Sartorius A. The possibility of contaminating the cells is restricting the 3D Cell Culture technologies market. Contamination of the cell culture refers to the presence of bacteria, moulds, yeasts, viruses, and mycoplasma that can adversely affect the cell culture. Contamination usually occurs when the cells are mishandled or due to the lack of adequate care, as a result the process of regeneration may get affected. According to a study conducted by Yale and Tuff's university, it was found that 3D cultures are more complex than 2D cell cultures and they require a more controlled cellular environment in order to mimic structures for tissue or organ transplants. Therefore, probability of cell culture contamination is relatively higher in 3D cell cultures. Implementing the latest technology is the latest trend in the 3D Cell culture market. For example, various companies have adopted one such advancement in the market for 3D cell culture, this is the use of the vivo/vitro environment. Cell expansion and interactions under 2D are not appropriate in vitro models but when compared with 3D cell culture technique, it offers a better cell culture environment. The Vitro environment enables researchers or doctors to conduct the procedure in a controlled environment outside the organism. This procedure is gaining importance as it plays a vital role in monitoring the health of patients. FDA approved Biotek's 3D cell expansion system to be used as a medical device. It also approved Biotek's Polycaprolactone (PCL) which is a biodegradable polyester material that is used in many FDA-approved implants and drug delivery devices. FDA regulates the cell culture technologies under title 21, sec 864.2240. FDA states that cell and tissue culture technologies should be labelled or mentioned as sterile, or else they would be removed from the good manufacturing practice of the quality system. Each technology unit should maintain procedures to receive, review, and evaluate complaints. These procedures should also include consistent documentation of the receipts. In May 2021, CELLINK Group, a USA-based start-up that designs and supplies technologies and services to enhance biology research, has acquired Visikol Corporation for $7.5 million. With this acquisition, CELLINK made an entrance into the contract research market. Visikol Corp., an American contract research services company that provides pharma and biotech industries with leading services in 3D cell culture, 3D tissue imaging, multiplex imaging, and digital pathology. North America was the largest region in the 3D cell culture technologies market in 2022. Western Europe was the second largest region in the 3D cell culture technologies market share. The regions covered in the global 3D cell culture technologies market report analysis are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa. The countries covered in the 3D cell culture technologies market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA. The 3D cell culture technologies market consists of sales of 3D cell culture technologies such as microfluidics, hydrogels scaffolds, scaffold-free 3D cell culture techniques, spheroids, cube, spherical droplet, stacked plate, magnetic bead, organ-on-chips and other technologies. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The 3D cell culture technologies market research report is one of a series of new reports from The Business Research Company that provides 3D cell culture technologies market statistics, including 3D cell culture technologies industry global market size, regional shares, competitors with a 3D cell culture technologies market share, detailed 3D cell culture technologies market segments, market trends and opportunities, and any further data you may need to thrive in the 3D cell culture technologies industry. This 3D cell culture technologies market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

3D printed medical devices are artificial devices that replace a missing body part or biological structure and are manufactured by laying successive layers of material using inputs from a digital 3D model. The main types of 3D printed medical devices are implants, surgical instruments, prosthetics, tissue engineering devices, and others. The 3D-printed implants are medical implants that are made using 3D printing technology to create complex geometries. These are made up of raw materials such as plastics, biomaterial inks, and metals and alloys. The technologies involved in 3D printed medical devices are fused deposition modeling, digital light processing, stereolithography, and selective laser melting. These provide applications in orthopedic, spinal, dental, hearing aids, and others that are used by end-users such as hospitals, diagnostics centres, academic institutions, and others. The global 3D printed medical devices market is segmented – 1) By Type: Implants, Surgical instruments, Prosthetics, Tissue engineering devices, Other Types 2) By Application: Orthopedic, Spinal, Dental, Hearing Aids, Other Applications 3) By Technology: Fused Deposition Modelling, Digital Light Processing, Stereolithography, Selective Laser melting 4) By Raw Material: Plastics, Biomaterial inks, Metals and Alloys 5) By End User: Hospitals, Diagnostics Centres, Academic Institutions, Other End Users The global 3d printed medical devices market size grew from $2.87 billion in 2022 to $3.57 billion in 2023 at a compound annual growth rate (CAGR) of 24.5%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The market size of global 3d printed medical devices is expected to grow to $9.09 billion in 2027 at a CAGR of 26.3%. The increasing prevalence of osteoarthritis and similar musculoskeletal conditions is one of the major factors driving the growth of the 3D printed medical devices market. Osteoarthritis is a disorder that damages the joint cartilage and surrounding tissues causing pain, stiffness, and loss of joint function to the person affected by it. The 3D printing medical devices enable the creation of a replica of a patient's joint, which can provide surgeons with a crucial piece of information that might not be visible on a 2-dimensional scan. The chance of developing osteoarthritis increases with age. For instance, according to the US National Library of Medicine report, by 2040, it is estimated that approximately 78 million (26%) US adults aged 18 years and above will be projected to have doctor-diagnosed arthritis. Thereby driving the adoption of 3D printed medical devices, positively impacting the 3d printed medical devices market growth. Major players in the 3D printed medical devices market are 3D Systems Corporation, EnvisionTEC, Stratasys Ltd., Arcam AB, Cyfuse Biomedical, Materialise NV, Organovo Holdings, EOS GmbH, FabRx Ltd., and Concept Laser. Biocompatibility issues related to 3D printed medical devices restrict the growth of the 3D printed medical devices market. Biocompatibility implies the properties that make a material or a device compatible with the human body. If the material used for the preparation of a 3D printed implant device is not compatible with the patients' biomechanics, then patients may suffer side effects such as abnormal growth of bone and bleeding. Among the most common metal used in the manufacturing of 3D printed medical devices is Titanium. Though Titanium offers reliability and accuracy in creating medical-grade products, some human bodies tend to reject titanium as its chemical composition can inhibit the bone and tissue from interacting with the implant. Apart from these other reasons which may contribute to the failure of metallic implants that are either caused by the material properties of the metal (e.g., high stiffness, high corrosion rate, and toxicity) itself or by the exposure of the bone to infected metal implants i.e., infection. The increasing use of 3D printing technology in the spine industry is one of the latest trends in the 3D printed medical devices market. The spine industry is adopting 3D printing to produce new innovative products that can promote bone ingrowth and improve implant fixation to spine bone, reducing the number of manufacturing steps, thereby making the 3D printing process more cost-effective in several cases. For instance, Medtronic launched its titanium 3D printed platform – TiONIC Technology. TiONIC Technology is a 3D printed technique that uses laser methods to create implants with enhanced surface textures. Artic-L is the first implant created by the company using TiONIC Technology. The implant is made up of titanium and is designed to be used by surgeons in spine surgery. In addition to that, K2M’s Lamellar, introduced its 3D Titanium Technology to create a 3D spinal implant. The 3D printing medical device using titanium technology uses an advanced 3D printing method to create structures that were once considered impractical with traditional manufacturing techniques. The implants use titanium powder and are associated with bone growth activity. Food and Drug Administration (FDA) has a Centre for Device and Radiological Health (CDRH) to regulate the firm which manufacture, repackage, relabel and/or import 3D printing medical devices in the US. FDA provides manufacturers with a draft with guidance that includes recommendations for device design, manufacturing, and testing considerations during the development of 3D printing medical devices. Section F of the 'Technical Considerations for Additive Manufactured Medical Device' draft, requires the manufacturers to evaluate the biocompatibility of the final finished device as described in the guidance "Use of International Standard ISO-10993". The guidelines also require the manufacturer of the 3D printing devices to mention the additional information in the label if any toxic chemical additives such as certain additives, catalysts, binding and curing agents, uncured monomers, and plasticizers are used in making 3D printing medical devices. In July 2020, Medtronic, an American Irish-domiciled medical device company acquired Medicrea International for an undisclosed amount. The acquisition of Medicrea expands Medtronic’s already deep portfolio as this adds to their spinal solution profile as the advent of new digital technology will offer the ability to custom spinal implants. Medicrea International is a spinal surgery company with 30+ FDA-approved spinal implant technologies that have been utilized in over 150,000 spinal surgeries to date. North America was the largest region in the 3D printed medical devices market in 2022. Western Europe was the second largest region in the 3D printed medical devices market. The regions covered in the 3D printed medical devices market analysis report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa. The countries covered in the 3D printed medical devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, and USA. The 3D printed medical devices market consists of sales of 3D printed prosthetics and implants. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The 3D printed medical devices market research report is one of a series of new reports from The Business Research Company that provides 3D printed medical devices market statistics, including 3D printed medical devices industry global market size, regional shares, competitors with a 3D printed medical devices market share, detailed 3D printed medical devices market segments, market trends and opportunities, and any further data you may need to thrive in the 3D printed medical devices industry. This 3D printed medical devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

3D medical imaging is a cutting-edge optical imaging technology that produces enlarged images of the interior of the body for medical examination. 3D medical imaging is used to create three dimensions’ visual representation of interior body parts for medical analysis with the help of computer-aided design (CAD) or a magnetic resonance image (MRI). The main types in 3D medical imaging are ultrasound, X-ray, CT scan, and others. The x-rays are used to capture images that are 2D and create the illusion of 3D x-ray imaging. The various applications are gynecology and obstetrics, cardiology, neurology, orthopedics, and oncology that are used by various end-users such as diagnostic centres, hospitals, and research centres. The global 3D medical imaging devices market is segmented – 1) By Type: Ultrasound, X-ray, CT Scan, Other Types 2) By End User: Diagnostic Centers, Hospitals, Research Centers 3) By Application: Gynecology and Obstetrics, Cardiology, Neurology, Orthopedics, Oncology The global 3D medical imaging devices market size will grow from $15.36 billion in 2022 to $16.27 billion in 2023 at a compound annual growth rate (CAGR) of 5.9%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The market size of global 3D medical imaging devices is expected to grow to $20.45 billion in 2027 at a CAGR of 5.9%. Increasing cases of injuries such as sports-related injuries contribute to the growth of the 3D medical imaging devices market. The increase in sports-related injuries is due to the increasing participation of individuals in organized and unorganized sports activities. Moreover, the training of athletes with high strength and high load also results in more and more serious injuries. Sports injuries are mainly characterized by soft tissue injury. The use of 3D medical imaging devices such as ultrasound diagnosis, X-ray radiography, MRI imaging provides an accurate and objective basis for the diagnosis. The 3D medical imaging devices help in the examination of muscle fascia injury, tendon injury, ligament injury, meniscus injury, articular cartilage, and bone fracture. According to the Centre for the Disease Control and Prevention, it is estimated that there are 775,000 emergency room visits due to the injuries in children who are participating in unorganized and organized sports activities. Thus, the increase in demand for 3D medical imaging devices favors the market growth. Major players in the 3D medical imaging devices market are GE Healthcare, Royal Philips, Siemens AG, The Esaote Group, Intrasense SA, Materialize NV, Toshiba Group, Samsung Medison Co. Ltd., Shimadzu Corporation, and Analogic Corporation The difficulties faced by the medical device industry owing to the COVID-19 outbreak such as the slowdown in orders and supply chain disruptions are likely to restraint the growth of the 3D medical imaging devices market over the next coming years. According to Medical Products Outsourcing (MPO) magazine published in April 2020, financial strains and supply chain disruptions are the major challenges faced by the medical devices industry. The manufacturers are experiencing a modest slowdown in orders attributed to tight management of inventories due to fear of the spread of the virus and slow pace of reorders owing to the impact of the virus on businesses. Moreover, the managers are also hesitant in overseeing the new product launches in uncertain times. This scenario is predicted to act as a major factor restraining the growth of the market shortly. 3D medical imaging device manufacturers are increasingly investing in Artificial Intelligence (AI) to improve the diagnosis by giving accurate, hard-number measurements. AI provides efficiency in medical imaging, particularly when it comes to detecting organs or anomalies. For instance, by combining image visualization and AI, cardiologists can measure ejection fraction with high precision and in a much shorter period. Ejection fraction is a measurement of the percentage of blood leaving the heart each time it contracts. For instance, In November 2021, GE Healthcare, a company operating in 3D imaging devices unveiled 60 innovative technology solutions including artificial intelligence to transform healthcare to help patients and clinicians with an effective way of solutions. In February 2020, Alphatec Holdings, Inc. (ATEC or the Company) acquired EOS imaging, SA for a purchase price of about $88 million. With this acquisition, ATEC will integrate spine imaging and anatomical modeling for better operative performance and is expected to significantly increase the demand for ATEC hardware and EOS systems. EOS Imaging is a France-based medical device company leading in orthopedic medical imaging solutions. Western Europe was the largest region in the 3D medical imaging devices market in 2022. Asia-Pacific was the second-largest region in the 3D medical imaging devices market report. The regions covered in the global 3D medical imaging devices industry report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa. The countries covered in the 3D medical imaging devices market are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, and USA. The 3D medical imaging devices market consists of sales of ultrasound, magnetic resonance imaging (MRI), radiography, and computed tomography scan (CT). Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The 3D medical imaging devices market research report is one of a series of new reports from The Business Research Company that provides 3D medical imaging devices market statistics, including 3D medical imaging devices industry global market size, regional shares, competitors with a 3D medical imaging devices market share, detailed 3D medical imaging devices market segments, market trends and opportunities, and any further data you may need to thrive in the 3D medical imaging devices industry. This 3D medical imaging devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The mobile device management refer to a proven methodology and toolset that is being used to provide mobile productivity tools and applications while keeping corporate data secure. MDM is a type of security software used by an IT department for monitoring, managing, and securing employees' mobile devices like laptops, smartphones, and tablets that are deployed across multiple mobile service providers and across multiple mobile operating systems being used in the organization. The main types of mobile device management are solutions and services. MDM (mobile device management) is a form of management or security technology that allows IT administrators to monitor, manage, and protect corporate or personal mobile devices that operate on a variety of operating systems. Mobile device management is compatible with iOS, Android, Windows, Mac OS, and other operating systems (linux) that can be deployed on-premises, in the cloud, or by small, medium, and large businesses.The various verticals using mobile device management are banking, financial services and insurance, telecom, retail, healthcare, education, transport and logistics, government and public sector, manufacturing and automotive, and other verticals (information technology). The global mobile device management market is segmented - 1) By Component: Solution, Services 2) By Operating System: iOS, Android, Windows, MacOS, Other Operating systems (Linux) 3) By Deployment Mode: On-Premises, Cloud 4) By Organisation Size: Small and Medium Enterprises, Large Enterprises 5) By Vertical: Banking, Financial Services and Insurance, Telecom, Retail, Healthcare, Education, Transport and Logistics, Government and Public Sector, Manufacturing and Automotive, and Other Verticals The global mobile device management market size will grow from $7.34 billion in 2022 to $8.7 billion in 2023 at a compound annual growth rate (CAGR) of 18.5%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The market size of the mobile device management market size is expected to grow to $22.01 billion in 2027 at a CAGR of 26.1%. The immense growth of the mobile workforce within enterprises is contributing to the growth of the mobile device management market. A mobile workforce refers to a group of employees that isn’t bound by a central physical location. Companies are increasingly using mobile device management for monitoring and security of mobile devices, such as smartphones and tablets, in the workplace. The strong growth in the workforce and the need to secure connectivity among the workforce is expected to boost the mobile device management market. For instance, according to a new forecast from International Data Corporation, a US-based data examiner, in 2020, the U.S. mobile worker population will increase at a constant rate over the next four years, increasing from 78.5 million in the year 2020 to 93.5 million mobile workers by the year 2024. By the end of the forecast period, IDC is expecting mobile workers to account for nearly 60% of the total U.S. workforce. Major players in the mobile device management market are Vmware, Microsoft, IBM, Blackberry, Citrix, Google, Cisco, Samsung, ZOHO, SAP, Quest Software, Ivanti, Sophos, SOTI, Jamf, Matrix 42, 42Gears, Mitsogo Inc., MobileIron, Broadcom, Inc., Kaspersky Labs, Codeproof Technologies, Micro Focus, Baramundi, Kandji, Miradore Ltd., Centrify Corporation, ManageEngine, FiberLink Communications, LLC, and Apple Inc. Technological advancement is a key trend gaining popularity in the mobile device management market. The key players in the market are launching innovative products to provide an enhanced experience to their enterprise users. For instance, in January 2020, Sophos Ltd. launched Sophos Intercept X for mobile with new security capabilities. This new solution will protect users, devices, and data from known and unknown mobile threats. In December 2020, Ivanti, a US-based mobile device management company, acquired MobileIron for an undisclosed amount. This acquisition enables customers to collaborate and innovate freely while reducing the risk of data breaches and enhancing employee experiences. MobileIron is a US-based company and a leading provider of mobile-centric unified endpoint management solutions. North America was the largest region in the mobile device management market in 2022. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the mobile device management market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa. The countries covered in the mobile device management market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA. The mobile device management market includes revenues earned by entities by providing software tools that automate the processes of managing and securing an organization's fleet of mobile devices and protects corporate data by controlling apps, content, and accessibility on managed devices. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The mobile device management market research report is one of a series of new reports from The Business Research Company that provides mobile device management market statistics, including mobile device management industry global market size, regional shares, competitors with a mobile device management market share, detailed mobile device management market segments, market trends and opportunities, and any further data you may need to thrive in the mobile device management industry. This mobile device management market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Mobile healthcare refers to a branch of electronic health, which is defined as public and medical health practise supported by mobile devices. Healthcare devices are utilised for the collection and storage of patient information to obtain accurate results, which are used to diagnose and treat various medical conditions. The main types of mobile healthcare devices include blood glucose monitors, cardiac monitors, hemodynamic monitors, neurological monitors, respiratory monitors, body and temperature monitors, remote patient monitoring devices, and others. Blood glucose monitors are small, portable machines used to measure blood sugar levels in the blood. Types of mobile healthcare services include treatment services, diagnostic services, monitoring services, wellness and fitness solutions, and others. The stakeholders associated with mobile healthcare include mobile operators, healthcare providers, application and content players, and others. The global mobile healthcare market is segmented - 1) By Device Type: Blood Glucose Monitors, Cardiac Monitors, Hemodynamic Monitors, Neurological Monitors, Respiratory Monitors, Body and Temperature Monitors, Remote Patient Monitoring Devices, Other Device Types 2) By Service Type: Treatment Services, Diagnostic Services, Monitoring Services, Wellness and Fitness Solutions, Other Service Types 3) By Stake Holder: Mobile Operators, Healthcare Providers, Application/Content Players, Other Stake Holders The global mobile healthcare market size will grow from $83.06 billion in 2022 to $106.74 billion in 2023, at a compound annual growth rate (CAGR) of 28.5%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The market size of the mobile healthcare is expected to grow to $309.49 billion in 2027 at a CAGR of 30.5%. The increase in incidence of chronic diseases globally is significantly contributing to the growth of the mobile healthcare market. For example, one in every three adults worldwide suffers from multiple chronic conditions, with prevalence rates ranging from 16% to 58% in UK studies, 26% in US studies, and 9.4% in urban South Asians. Therefore, the growing incidence of chronic diseases globally is driving the mobile healthcare market growth. Apple Inc., Koninklijke Philips N.V., Omron Corporation, athenahealthInc., iHealth Labs Inc., AT & T, Samsung Electronics Co., Ltd., Vodafone Group, Dexcom Inc., Masimo Corporation, Qualcomm Technologies Inc., AliveCorInc., Nike Inc., BioTelemetry Inc., AgaMatrix Inc., Withings SA, Telefonica SA, SoftServe, and Google Inc., are major players in the mobile healthcare market. Cloud-based mobile health is the major trend gaining popularity in the mobile healthcare market. Cloud-based mobile healthcare uses the cloud, mobile devices, such as mobile phones, tablet computers, personal digital assistants (PDAs), and wearable devices such as smart watches, for health services and data collection. Cloud-based systems offer flexibility and reduced costs compared to traditional servers. Using the cloud, patient information can be accessed by doctors from any location. Major players in cloud computing, such as Amazon, Microsoft, and Google, also operate in the mHealth space. In June 2020, Chronometriq, a US-based leader in healthcare management, released MagicSeat, a virtual queue management system for clinics. In February 2021, Philips, a Dutch multinational health technology company headquartered in Amsterdam, acquired BioTelemetry Inc., for an undisclosed amount. The acquisition is a strong fit with Philips’ leading patient monitoring position in the hospital and BioTelemetry’s leading cardiac monitoring and diagnostics position outside the hospital. BioTelemetry, Inc., is a leading remote cardiac diagnostics and monitoring services provider in the United States. North America was the largest region in the mobile healthcare market in 2022. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the mobile healthcare report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa. The countries covered in the Mobile Healthcare market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA. The mobile healthcare market includes revenues earned by entities by helping users track their biorhythms, monitor sleep, calories, diet, well-being and allowing users to place an order and then have the needed medication delivered. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The mobile healthcare market research report is one of a series of new reports from The Business Research Company that provides mobile healthcare market statistics, including mobile healthcare industry global market size, regional shares, competitors with mobile healthcare market share, detailed mobile healthcare market segments, market trends and opportunities, and any further data you may need to thrive in the mobile healthcare industry. This mobile healthcare market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Mobile CRM software refers to an application that is designed to be operated, executed, and accessed through mobile platforms. Mobile CRM, or mobile customer relationship management, allows field workers and remote employees to access customer information and accounts from any location using mobile devices such as tablets and smartphones. It is used to provide increased productivity, performance, and quality for management. The main types of mobile CRM software are cloud-based and on-premise. Cloud-based software is hosted in the cloud, which means that organizations may access and store client data over the internet. This eliminates the need for the company to worry about data management and storage, as well as the cost of purchasing separate licences for various devices. The mobile CRM software is used in BFSI, telecom, healthcare, retail, automotive, and others. These mobiles are often used by large enterprises, medium enterprises, and small enterprises. The global mobile crm software market is segmented - 1) By Type: Cloud Based, On-Premise 2) By Enterprise: Small Enterprise, Medium Enterprise, Large Enterprise 3) By Vertical: BFSI, Telecom, Healthcare, Retail, Automotive, Other Verticals The global mobile crm software market size will grow from $23.48 billion in 2022 to $26.64 billion in 2023 at a compound annual growth rate (CAGR) of 13.5%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The market size of the mobile crm software is expected to grow to $43.57 billion in 2027 at a CAGR of 13.1%. The rise in adoption for mobile CRM in the retail, banking, and finance industry across the globe is expected to propel the growth of the mobile CRM software market going forward. Mobile CRM allows customers' data to be tracked across the bank, including in-service and loan origination departments. It can also help banks give clients a digital banking experience.For instance, in October 2022, according to ThriveMyWay, a Bulgaria-based blogging firm, 92% of companies claimed CRM was crucial to helping them reach their revenue targets.. Further, according to the SuperOffice, a cloud-based CRM platform, mobile CRM is currently considered a mainstream approach for tapping into a company's client base, according to 61% of organizations, and 65% of sales representatives who used it were able to meet their targets. Thus, the rising adoption of mobile CRM by the retail, banking, and finance industries drives the mobile CRM software market growth. Major players in the mobile CRM software market are Zoho, HubSpot, Zendesk, Microsoft Corporation, Oracle Corporation, SAP SE, Sybase, Kony Solutions, Resco.net, Software AG, RepslyInc., Pegasystems Inc., AMDOCS, Spiro, Bitrix24, HarmonyPSA, Agile CRM, Thryv, Pipeliner CRM, Freshsales, and Salesforce.com Inc. Integration of artificial intelligence with CRM software is a key trend gaining popularity in the mobile CRM software market. AI-powered mobile CRM will compare performance over a specified time period in terms of productivity, velocity, winning percentage, and efficiency, as well as give completed leads, opportunities, accounts, and contacts. For instance, in April 2022,Salesforce, Inc a US-based cloud-based software company, CRM analytics with artificial intelligence capabilities to provide more individualized experiences for customers, these technologies assist sales executives, service leaders, and staff members across many industries, including financial services, manufacturing, consumer products, and communications. In February 2020, Salesforce, a US-based cloud company offering CRM software acquired Vlocity Inc., for $1.33 billion. Under this deal, Salesforce will completely acquire Vlocity and aims to expand into insurance and financial services, communications, health, media and entertainment, utilities, energy and government, and nonprofit CRMs. Vlocity is a US-based company that offers industry-specific CRM solutions and mobile CRM software. North America was the largest region in the mobile CRM software market in 2022. The regions covered in the mobile CRM software market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa. The countries covered in the mobile CRM software market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, and USA. The mobile CRM software market includes revenues earned by entities by streamlining integration with other communications tools, responding to customers faster and better, and accessing data everywhere. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The mobile CRM software research report is one of a series of new reports from The Business Research Company that provides mobile CRM software statistics, including mobile CRM software industry global market size, regional shares, competitors with mobile CRM software share, detailed mobile CRM software segments, market trends and opportunities, and any further data you may need to thrive in the mobile CRM software industry. This mobile CRM software research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

3D printed prosthetics are artificial devices that replace a missing body part and are manufactured by laying successive layers of material using inputs from a digital 3D model. The main types in the 3D printed medical prosthetics are sockets, limbs, joints, covers, and others. The prosthetic limbs are used as artificial limbs for those who need limbs. These are made up of various materials such as polypropylene, polyethylene, acrylics, and polyurethane. These are used by end-users such as hospitals, rehabilitation centres, and prosthetic clinics. The global 3D printed prosthetics market is segmented - 1) By Material: Polypropylene, Polyethylene, Acrylics, Polyurethane 2) By Type: Sockets, Limbs, Joints, Covers, Other Types 3) By End-User: Hospitals, Rehabilitation Centers, Prosthetic Clinics The global 3D printed prosthetics market size will grow from $0.96 billion in 2022 to $1.04 billion in 2023 at a compound annual growth rate (CAGR) of 8.8%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The market size of global 3D printed prosthetics is expected to grow to $1.44 billion in 2027 at a CAGR of 8.4%. The rising number of accidental injuries is driving the growth of the 3D printed prosthetics market. Accidental injuries can cause serious damage to a person, and these injuries can sometimes lead to amputation. In2021, car crashes in the US resulted in the death of 42915 people which was the highest in 16 years. According to a report from National Centre for Health Statistics, approximately 50,000 new amputation cases come up each year in the US. An increase in incidences of other medical conditions such as diabetes and vascular diseases is also leading to a rise in amputation cases, thus boosting the sales of 3D printing prosthetics. For instance, according to a report published in the American Journal of Managed Care, it was estimated that, globally, one patient leg is amputated every 30 seconds and around 85% of these amputations were a result of a diabetic foot ulcer. Major players in the 3D printed prosthetics market are 3D Systems Corporation, EnvisionTEC, Stratasys Ltd., Bionicohand, YouBionic, UNYQ, Mercurys, LimbForge Inc., Open Bionics, Protosthetics, and Create Prosthetics. The delay in elective procedures attributed to the coronavirus outbreak is to act as a major factor to limit the growth of the 3D printed prosthetics market. Many countries and hospitals have diverted their healthcare resources to deal with COVID-19 patients. For instance, according to the Centers for Medicare & Medicaid Services (CMS) safety guidelines released in March 2020, all the elective and non-essential surgical, dental, and medical procedures are delayed in the USA during the 2019 Novel Coronavirus (COVID-19) outbreak. Hence, the delays in surgical or elective procedures are projected to decline the 3D printed prosthetics market demand shortly. Companies in the 3D printing prosthetics market are focusing on the development of waterproof prosthetic devices. The aim behind this innovation is to provide the user with an increased range of mobility, especially in athletics. In October 2020, Braskem, Americas leading producer of biopolymers has launched Braskem e-NABLE Chapter for Philanthropic Creation of 3D Printed Prosthetic Devices. Braskem was selected to be certified to produce the e-NABLE Phoenix V3 prosthetic hand as it is one of the most commonly produced e-NABLE prosthetic devices. North America was the largest region in the 3D printed prosthetics market in 2022. Asia-Pacific was the second-largest region in the 3D printed prosthetics market. The regions covered in 3D printed prosthetics market analysis report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa. The countries covered in the 3D printed prosthetics market are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, and USA. The 3D printed prosthetics market consists of sales of 3D printed instruments such as sockets, limbs, joints, covers, and others. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The 3D printed prosthetics market research report is one of a series of new reports from The Business Research Company that provides 3D printed prosthetics market statistics, including 3D printed prosthetics industry global market size, regional shares, competitors with a 3D printed prosthetics market share, detailed 3D printed prosthetics market segments, market trends and opportunities, and any further data you may need to thrive in the 3D printed prosthetics industry. This 3D printed prosthetics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.